Reflect Scientific Inc. Releases Second Quarter 2022 Financials
Reflect Scientific Inc. Releases Second Quarter 2022 Financials
OREM, Utah, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, today announced financial results for the second quarter of 2022.
猶他州奧雷姆，2022年8月10日(Global Newswire)--Reflect Science，Inc.(代碼：RSCF)是一家為生物技術、製藥和運輸行業提供多種產品和服務的公司，今天公佈了2022年第二季度的財務業績。
"The supply chain issues plaguing U.S industries have recently affected some of the Reflect products. Although we anticipated much of the shipping delays and parts availability, we were finally hit with some shortages. We have been diligently researching workarounds and replacements. I do not expect this situation to extend past the third quarter." stated Mr. Kim Boyce, CEO of Reflect Scientific.
“最近，困擾美國行業的供應鏈問題影響了Reflect的一些產品。儘管我們預料到了大部分發貨延遲和零部件供應，但我們最終還是遇到了一些短缺。我們一直在努力研究解決辦法和更換方法。我預計這種情況不會持續到第三季度以後。”Reflect Science的首席執行官金·博伊斯先生説。
The following unaudited table summarizes revenue, cost of goods sold, and operating expenses for the three months ended June 30, 2022 and 2021:
以下未經審計的表格彙總了截至2022年6月30日和2021年6月30日的三個月的收入、銷售成本和運營費用：
| Three Months Ended June 30, 2022 |
Three Months Ended June 30, 2021 |
Increase (Decrease) |
|||||
| Revenue | $ | 555,615 | $ | 707,133 | $ | (151,518 | ) |
| Cost of Goods Sold | 195,821 | 235,179 | (39,358 | ) | |||
| Gross Profit | 359,794 | 471,954 | (112,160 | ) | |||
| Operating expenses: | |||||||
| Salaries and wages | 159,565 | 146,116 | 13,449 | ||||
| Research and development expense | 18,329 | 19,456 | (1,127 | ) | |||
| General and administrative expense | 103,775 | 135,601 | (31,826 | ) | |||
| Total operating expenses | 281,669 | 301,173 | (19,656 | ) | |||
| Income (loss) from operations | 78,125 | 170,781 | (92,656 | ) | |||
| Net income (loss) | $ | 78,125 | $ | 170,781 | $ | (92,656 | ) |
| 三個月 截至6月30日， 2022 |
三個月 截至6月 30, 2021 |
增加 (減少) |
|||||
| 收入 | $ | 555,615 | $ | 707,133 | $ | (151,518 | ) |
| 銷貨成本 | 195,821 | 235,179 | (39,358 | ) | |||
| 毛利 | 359,794 | 471,954 | (112,160 | ) | |||
| 運營費用： | |||||||
| 薪金和工資 | 159,565 | 146,116 | 13,449 | ||||
| 研發費用 | 18,329 | 19,456 | (1,127 | ) | |||
| 一般和行政費用 | 103,775 | 135,601 | (31,826 | ) | |||
| 總運營費用 | 281,669 | 301,173 | (19,656 | ) | |||
| 營業收入(虧損) | 78,125 | 170,781 | (92,656 | ) | |||
| 淨收益(虧損) | $ | 78,125 | $ | 170,781 | $ | (92,656 | ) |
About Reflect Scientific, Inc.
Reflect Science公司簡介
Based in Orem, Utah, Reflect Scientific develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific's products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit reflectscientific.com for more information. See us on Twitter @ReflectSci and on LinkedIn at .
總部設在猶他州奧雷姆的Reflect Science公司為生物技術、製藥、醫療和運輸市場開發和營銷創新的低温冷卻專有技術。Reflect Science的產品包括用於實驗室、運輸和計算機服務器機房的低温冷凍機和製冷系統。有關更多信息，請訪問ReflectScience fic.com。在Twitter@ReflectSci和LinkedIn上查看我們的地址。
Forward-Looking Statements
前瞻性陳述
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol "RSCF" and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading "Disclosure," including those identified in such filings as "forward-looking statements."
本新聞稿包含符合修訂後的1933年證券法第27A節和修訂後的1934年證券交易法第21E節的前瞻性陳述。前瞻性陳述不是對未來業績或結果的保證，也不一定準確地説明實現業績或結果的時間或方式。前瞻性陳述以作出陳述時可獲得的信息為基礎，涉及已知和未知的風險、不確定因素和其他因素，這些風險、不確定性和其他因素可能會導致我們的結果、活動水平、業績或成就與本新聞稿中前瞻性陳述明示或暗示的信息大不相同。考慮本新聞稿時，應參考場外交易市場集團LLC以“RSCF”為交易代碼提交的公司文件中所包含的披露，以及其中引用幷包含在證券交易委員會埃德加檔案“披露”標題下的公司先前的相關文件，包括在此類文件中標識為“前瞻性陳述”的那些文件。
CONTACT: Contact Thomas Tait 801-607-1039 investor_relations@reflectscientific.com
聯繫人：Contact：Contact：Thomas Tait電話：801-607-1039